BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Lupus Nephritis

In brief

The primary objective of the study is to assess the efficacy of BIIB023 as an add-on treatment to background therapy compared with placebo in combination with background therapy in the treatment of participants with active, biopsy-proven lupus nephritis. The secondary objectives of this study are to assess the safety and tolerability of BIIB023 compared with placebo in this study population.

Key facts

Study ID
NCT01499355
Run by
Biogen
People needed
276
Starts
2012-07-01
Expected to finish
2015-12-01
Last updated by the study team
2017-01-18

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.